Correlation Between Veracyte and Cyclerion Therapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Cyclerion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Cyclerion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Cyclerion Therapeutics, you can compare the effects of market volatilities on Veracyte and Cyclerion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Cyclerion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Cyclerion Therapeutics.
Diversification Opportunities for Veracyte and Cyclerion Therapeutics
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Veracyte and Cyclerion is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Cyclerion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclerion Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Cyclerion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclerion Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Cyclerion Therapeutics go up and down completely randomly.
Pair Corralation between Veracyte and Cyclerion Therapeutics
Given the investment horizon of 90 days Veracyte is expected to generate 1.55 times less return on investment than Cyclerion Therapeutics. But when comparing it to its historical volatility, Veracyte is 2.97 times less risky than Cyclerion Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Cyclerion Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 245.00 in Cyclerion Therapeutics on September 3, 2024 and sell it today you would lose (25.00) from holding Cyclerion Therapeutics or give up 10.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Veracyte vs. Cyclerion Therapeutics
Performance |
| Timeline |
| Veracyte |
| Cyclerion Therapeutics |
Veracyte and Cyclerion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Cyclerion Therapeutics
The main advantage of trading using opposite Veracyte and Cyclerion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Cyclerion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclerion Therapeutics will offset losses from the drop in Cyclerion Therapeutics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Cyclerion Therapeutics vs. Kronos Bio | Cyclerion Therapeutics vs. Larimar Therapeutics | Cyclerion Therapeutics vs. Addex Therapeutics | Cyclerion Therapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |